Literature DB >> 16015601

When contractile proteins go bad: the sarcomere and skeletal muscle disease.

Nigel G Laing1, Kristen J Nowak.   

Abstract

The sarcomere is the functional unit of striated muscle contraction. Mutations in sarcomeric proteins are now known to cause around 20 different skeletal muscle diseases. The diseases vary in severity from paralysis at birth, to mild conditions compatible with normal life span. The identification of the disease genes allows more accurate diagnosis, including prenatal diagnosis. Although many disease genes have been identified, the pathophysiology of the gene defects remains remarkably obscure, considering that many of the proteins have been researched for decades. The short-term goals are to determine the remaining disease genes and to decipher pathogenesis. The long-term goal is to develop effective therapies-a daunting task when humans are up to 40% muscle and the mutated proteins are fundamental to muscle contraction. The affected patients and families hope for help sooner rather than later. The onus is on all scientists researching sarcomeric proteins to help develop treatments. 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16015601     DOI: 10.1002/bies.20269

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  41 in total

1.  Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1.

Authors:  Christina A Gurnett; David M Desruisseau; Kevin McCall; Ryan Choi; Zachary I Meyer; Michael Talerico; Sara E Miller; Jeong-Sun Ju; Alan Pestronk; Anne M Connolly; Todd E Druley; Conrad C Weihl; Mathew B Dobbs
Journal:  Hum Mol Genet       Date:  2010-01-02       Impact factor: 6.150

2.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

Review 3.  Myosin binding protein-C: an essential protein in skeletal and cardiac muscle.

Authors:  Pradeep K Luther; Anupama Vydyanath
Journal:  J Muscle Res Cell Motil       Date:  2011-01-13       Impact factor: 2.698

Review 4.  Targeting the sarcomere to correct muscle function.

Authors:  Peter M Hwang; Brian D Sykes
Journal:  Nat Rev Drug Discov       Date:  2015-04-17       Impact factor: 84.694

5.  Theoretical and experimental SHG angular intensity patterns from healthy and proteolysed muscles.

Authors:  Denis Rouède; Jean-Jacques Bellanger; Emmanuel Schaub; Gaëlle Recher; François Tiaho
Journal:  Biophys J       Date:  2013-05-07       Impact factor: 4.033

6.  Localization of sarcomeric proteins during myofibril assembly in cultured mouse primary skeletal myotubes.

Authors:  Jennifer White; Marietta V Barro; Helen P Makarenkova; Joseph W Sanger; Jean M Sanger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

7.  Myofibrillar misalignment correlated to triad disappearance of mdx mouse gastrocnemius muscle probed by SHG microscopy.

Authors:  Denis Rouède; Pascal Coumailleau; Emmanuel Schaub; Jean-Jacques Bellanger; Mireille Blanchard-Desce; François Tiaho
Journal:  Biomed Opt Express       Date:  2014-02-25       Impact factor: 3.732

8.  Jasplakinolide reduces actin and tropomyosin dynamics during myofibrillogenesis.

Authors:  Jushuo Wang; Yingli Fan; Dipak K Dube; Jean M Sanger; Joseph W Sanger
Journal:  Cytoskeleton (Hoboken)       Date:  2014-09-12

9.  Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7 is caused by a DES mutation.

Authors:  Carola Hedberg; Atle Melberg; Angelika Kuhl; Dieter Jenne; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2012-03-07       Impact factor: 4.246

10.  Skeletal muscle myopathy mutations at the actin tropomyosin interface that cause gain- or loss-of-function.

Authors:  Massimiliano Memo; Steven Marston
Journal:  J Muscle Res Cell Motil       Date:  2013-05-30       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.